eNOS haplotypes associated with gestational hypertension or preeclampsia

Pharmacogenomics

Volumn 9, Issue 10, 2008, Pages 1467-1473

  Sandrim, Valeria C ^a   Palei, Ana C T ^b   Cavalli, Ricardo C ^a   Araújo, Francielle M ^a   Ramos, Ester S ^a   Duarte, Geraldo ^a   Tanus Santos, Jose E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Endothelial nitric oxide synthase; eNOS; Gestational hypertension; Haplotypes; Nitric oxide; Polymorphisms; Preeclampsia

Indexed keywords

ANTIHYPERTENSIVE AGENT; ASPARTIC ACID; CYTOSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; THYMINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA;

ADULT; ALLELES; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; YOUNG ADULT;

EID: 55449090921     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.9.10.1467     Document Type: Article

References (37)

1. Sladek SM, Magness RR, Conrad KP: Nitric oxide and pregnancy. Am. J. Physiol. 272, R441-R463 (1997).
2. Forstermann U, Munzel T: Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113, 1708-1714 (2006).
3. Williams DJ, Vallance PJ, Neild GH, Spencer JA, Imms FJ: Nitric oxide-mediated vasodilation in human pregnancy. Am. J. Physiol. 272, H748-H752 (1997).
4. Weiner CP, Knowles RG, Moncada S: Induction of nitric oxide synthases early in pregnancy. Am. J. Obstet. Gynecol. 171, 838-843 (1994).
5. Seligman SP, Buyon JP Clancy RM, Young BK, Abramson SB: The role of nitric oxide in the pathogenesis of preeclampsia. Am. J. Obstet. Gynecol. 171, 944-948 (1994).
6. Choi JW, Im MW, Pai SH: Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann. Clin. Lab. Sci. 32, 257-263 (2002).
7. Sibai BM: Intergenerational factors: a missing link for preeclampsia, fetal growth restriction, and cardiovascular disease? Hypertension 51(4), 993-994 (2008).
8. Salonen Ros H, Lichtenstein F, Lipworth L, Cnattingius S: Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am. J. Med. Genet. 91, 256-260 (2000).
9. Krotz S, Fajardo J, Ghandi S, Patel A, Keith LG: Hypertensive disease in twin pregnancies: a review. Twin Res. 5, 8-14 (2002).
10. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 308, 1592-1594 (2005).
11. Roberts JM, Gammill HS: Preeclampsia: recent insights. Hypertension 46, 1243-1249 (2005).
12. Metzger IF, Sertorio JT, Tanus-Santos JE: Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic. Biol. Med. 43, 987-992 (2007).
13. Metzger IF, Souza-Costa DC, Marroni AS et al.: Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet. Genomics 15, 565-570 (2005).
14. Tanus-Santos JE, Desai M, Flockhart DA: Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11, 719-725 (2001).
15. Serrano NC, Casas JP, Diaz LA et al.: Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study. Hypertension 44, 702-707 (2004).
16. Landau R, Xie HG, Dishy V, Wood AJ, Stein CM, Smiley RM: No association of the Asp298 variant of the endothelial nitric oxide synthase gene with preeclampsia. Am. J. Hypertens. 17, 391-394 (2004).
17. Seremak-Mrozikiewicz A, Drews K, Mrozikiewicz PM: The-786T/C polymorphism of the endothelial nitric oxide synthase gene in preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 138(1) 118-119 (2007).
18. Hassan A, Gormley K, O'Sullivan M et al.: Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35, 654-659 (2004).
19. Crawford DC, Nickerson DA: Definition and clinical importance of haplotypes. Annu. Rev. Med. 56, 303-320 (2005).
20. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE: Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 186, 428-432 (2006).
21. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE: Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and Type 2 diabetes mellitus patients. Nitric Oxide 16, 348-355 (2007).
22. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE: Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with Type 2 diabetes mellitus. Atherosclerosis 189, 241-246 (2006).
23. Sandrim VC, Yugar-Toledo JC, Desta Z, Flockhart DA, Moreno H Jr, Tanus-Santos JE: Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy. J. Hypertens. 24, 2393-2397(2006).
24. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J. Obstet. Gynecol. 183, S1-S22 (2000).
25. Marroni AS, Metzger IF, Souza-Costa DC et al.: Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12, 177-182 (2005).
26. Walsh SW: Obesity: a risk factor for preeclampsia. Trends Endocrinol. Metab. 18, 365-370 (2007).
27. Johnson GC, Esposito L, Barratt BJ et al.: Haplotype tagging for the identification of common disease genes. Nat. Genet. 29, 233-237 (2001).
28. Tempfer CB, Dorman K, Deter RL, O'Brien WE, Gregg AR: An endothelial nitric oxide synthase gene polymorphism is associated with preeclampsia. Hypertens Pregnancy 20, 107-118 (2001).
29. Chen LK, Huang CH, Yeh HM et al.: Polymorphisms in the endothelial nitric-oxide synthase gene may be protective against preeclampsia in a Chinese population. Reprod. Sci. 14, 175-181 (2007).
30. Fatini C, Sticchi E, Gensini F et al.: Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow. J. Hypertens. 24, 1823-1829 (2006).
31. Yoshimura. T, Chowdhury FA, Yoshimura M, Okamura H: Genetic and environmental contributions to severe preeclampsia: lack of association with the endothelial nitric oxide synthase Glu298Asp variant in a developing country. Gynecol. Obstet. Invest. 56, 10-13 (2003).
32. Nejatizadeh, A, Kumar R, Stobdan T et al.: Endothelial nitric oxide synthase haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension. Free Radic. Biol. Med. 44(11), 1912-1918 (2008).
33. Balding DJ: A tutorial on statistical methods for population association studies. Nat. Rev. Genet. 7, 781-791 (2006).
34. Chappell S, Morgan L: Searching for genetic clues to the causes of pre-eclampsia. Clin. Sci. (Lond) 110, 443-458 (2006).
35. Uitterlinden AG, Fang Y, van Meurs JB, Pols HA, van Leeuwen JP: Genetics and biology of vitamin D receptor polymorphisms. Gene 338, 143-156 (2004).
36. Wang J, Dudley D, Wang XL: Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler. Thromb. Vase. Biol. 22, E1-E4 (2002).
37. Gabriel SB, Schaffner SF, Nguyen H et al.: The structure of haplotype blocks in the human genome. Science 296, 2225-2229 (2002).